Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia

被引：0
|
作者：
Shigeno, K
Nakamura, S
Naito, K
Yoshida, H
Fujisawa, S
Shinjo, K
Fujita, Y
Matsui, H
Sahara, N
Takeshita, A
Ohno, R
Ohnishi, K
机构：
[1] Hamamatsu Univ Sch Med, Dept Med 3, Hamamatsu, Shizuoka 43131, Japan
[2] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4583
引用
收藏
页码：264B / 264B
页数：1
相关论文
共 50 条
  • [41] Arsenic trioxide for the treatment of acute promyelocytic leukemia
    Lam, MSH
    Ignoffo, RJ
    CANCER PRACTICE, 2001, 9 (03) : 155 - 157
  • [42] Mechanism of Synergy Between Bortezomib and Arsenic Trioxide in Acute Promyelocytic Leukemia and Clinical Efficacy in Relapsed Patients
    Ganesan, Saravanan
    Chendamarai, Ezhilarasi
    Abu Alex, Ansu
    David, Sachin
    Jayandharan, Giridhara R.
    Balasubramanian, Poonkuzhali
    Ahmed, Rayaz
    Abraham, Aby
    Viswabandya, Auro
    George, Biju
    Srivastava, Alok
    Mathews, Vikram
    BLOOD, 2012, 120 (21)
  • [43] Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia
    Ammatuna, Emanuele
    Cavaliere, Annafranca
    Divona, Mariadomenica
    Amadori, Sergio
    Scambia, Giovanni
    Lo-Coco, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (03) : 341 - 341
  • [44] Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
    Fox, Elizabeth
    Razzouk, Bassem I.
    Widemann, Brigitte C.
    Xiao, Shaun
    O'Brien, Michelle
    Goodspeed, Wendy
    Reaman, Gregory H.
    Blaney, Susan M.
    Murgo, Anthony J.
    Balis, Frank M.
    Adamson, Peter C.
    BLOOD, 2008, 111 (02) : 566 - 573
  • [45] Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
    Au, Wing-Yan
    Tam, Sidney
    Fong, Bonnie M.
    Kwong, Yok-Lam
    BLOOD, 2008, 112 (09) : 3587 - 3590
  • [46] Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia
    Zhang, Xueya
    Pan, Jingxin
    ANNALS OF HEMATOLOGY, 2017, 96 (04) : 707 - 708
  • [47] Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
    Yinjun Lou
    Shanshan Suo
    Yin Tong
    Hongyan Tong
    Wenbin Qian
    Haitao Meng
    Wenyuan Mai
    Jian Huang
    Wenjuan Yu
    Jie Jin
    Annals of Hematology, 2014, 93 : 941 - 948
  • [48] Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
    Lou, Yinjun
    Suo, Shanshan
    Tong, Yin
    Tong, Hongyan
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    Huang, Jian
    Yu, Wenjuan
    Jin, Jie
    ANNALS OF HEMATOLOGY, 2014, 93 (06) : 941 - 948
  • [49] Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia
    Freyer, Craig W.
    Peterson, Chelsea E.
    Man, Yun
    Przespolewski, Amanda
    Baron, Jeffrey
    Luger, Selina M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 696 - 702
  • [50] Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia
    Xueya Zhang
    Jingxin Pan
    Annals of Hematology, 2017, 96 : 707 - 708
12345